Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Apremilast improved symptoms in patients with severe skin conditions.

PI3K/Akt pathway is crucial for hair growth and regeneration.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Consider benefits and risks of new alopecia treatments for safety.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

People with X-linked hypohidrotic ectodermal dysplasia have no sweat ducts and less, thinner hair.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Nanog gene boosts stem cells, helps hair growth, and may treat hair loss.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A man's gray hair got darker and thicker after using a psoriasis drug.